# Study of Nasal Insulin to Fight Forgetfulness - Device Study

> **NCT03857321** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 20 (actual)

## Conditions studied

- Mild Cognitive Impairment
- Cognitive Impairment

## Interventions

- **DRUG:** Insulin
- **OTHER:** Placebo
- **DEVICE:** intranasal nebulizer-like device

## Key facts

- **NCT ID:** NCT03857321
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-12
- **Primary completion:** 2019-09-27
- **Final completion:** 2019-09-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03857321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03857321, "Study of Nasal Insulin to Fight Forgetfulness - Device Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03857321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*